Liver tumour management presents a complex challenge to oncologists and multidisciplinary treatment teams.  Selective internal radiation therapy (SIRT) with SIR-Spheres® Y-90 resin microspheres administered by interventional radiologists is an approved local approach to managing liver tumours. Approximately 80,000 doses have been administered in more than 1,090 treatment centres worldwide.

In addition, new data from an array of large, multi-centre, international studies may support expanded use of SIR-Spheres Y-90 resin microspheres in appropriate patients. Results of the SIRFLOX study published in 2016 in the Journal of Clinical Oncology, show particular promise.  New first-line mCRC data from the 1100-patient combined SIRFLOX, FOXFIRE and FOXFIRE Global studies will be presented in the first half of 2017. In HCC, results from SARAH and SIRveNIB are also due in 2017 and results from the SORAMIC study are expected in 2018.

Now leaving

You are about to leave the Sirtex Web site. This link is provided to you as a service and will take you to a site maintained by a third party who is solely responsible for the content.

Please be aware that Sirtex takes no responsibility for content of these external sites, nor do we endorse, warrant or guarantee the products, services or information described or offered on other internet sites.

Click 'Continue' to proceed to the third-party Web site.



You are now leaving your current region

The Sirtex site you are linking to is intended only for healthcare practitioners and patients outside your current region. Any products discussed herein may have different approved product labeling; therefore, any information provided may not be appropriate for use in your region.

Click 'Continue' to proceed to the other Sirtex region Web site.



This content is intended for healthcare professionals only

By clicking "Yes" you are confirming that you are a healthcare professional. If you are not a healthcare professional, then please click "Go to Homepage" which will direct you to the Sirtex homepage.

Yes Go to Homepage